ClinicalTrials.gg
RecruitingNCT06890572Updated Mar 24, 2025

Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients

An interventional study of HEPA + VOC collecting filter purifier and fake air purifier in Rhinitis Allergic, sponsored by Yonsei University. Recruiting at 1 site in Korea, Republic of. Open to participants aged 19 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by Yonsei University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
19 Years to 60 Years
Sex
All
01

Study summary

This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic rhinitis who continue to require medication such as antihistamines and nasal spray steroids for allergic rhinitis are the subjects of this study.

Patients who participate in the study will install air purifiers for a certain period of time and observe the objective and subjective improvement of rhinitis symptoms. The study is conducted on two separate occasions for four weeks, and there is a two-week period between the two periods of no use of air purifiers. There are two types of air purifiers:

1)It is an air purifier with a HEPA filter and a VOC filter, and 2) a fake air purifier without air cleaning function.

Subjects are divided into Group A and Group B. Group A will receive a fake air purifier, and Group B will be assigned an air purifier with a HEPA + VOC collecting filter. After using the assigned air purifier for the first four weeks, you will have a period of not using it for two weeks, and then replace the air purifiers with each other and use it again for four weeks. When you first assign an air purifier, you will receive an air purifier with a certain filter It is randomly assigned without knowing whether both the researcher and the patient will receive a regular period.

During the study period, patients need to visit three times, including when registering for the study, and the study period is screened It will take about 5 months from the end of the air purifier operation

Read the detailed description

This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic rhinitis who continue to require medication such as antihistamines and nasal spray steroids for allergic rhinitis are the subjects of this study.

Patients who participate in the study will install air purifiers for a certain period of time and observe the objective and subjective improvement of rhinitis symptoms. The study is conducted on two separate occasions for four weeks, and there is a two-week period between the two periods of no use of air purifiers. There are two types of air purifiers:

1)It is an air purifier with a HEPA filter and a VOC filter, and 2) a fake air purifier without air cleaning function.

Subjects are divided into Group A and Group B. Group A will receive a fake air purifier, and Group B will be assigned an air purifier with a HEPA + VOC collecting filter. After using the assigned air purifier for the first four weeks, you will have a period of not using it for two weeks, and then replace the air purifiers with each other and use it again for four weeks. When you first assign an air purifier, you will receive an air purifier with a certain filter It is randomly assigned without knowing whether both the researcher and the patient will receive a regular period.

During the study period, patients need to visit three times, including when registering for the study, and the study period is screened It will take about 5 months from the end of the air purifier operation

A detailed chronological overview of the study is as follows

  1. Screening and Baseline Visits (Visit 1) Before the process of the study begins, the study subjects are fully explained about the entire research process and checked whether they meet the selection and exclusion criteria. If the selection criteria are met, a written consent form will be written, basic demographic information (gender, age, medical history (including allergic disease-related and surgical history), and drug administration history (four weeks before registration). We will conduct a survey on subjective symptoms of allergic rhinitis, drug use scores, subjective score indicators, and quality of life evaluation indicators, and double-check the drugs currently being taken by the study subjects.

    If you have previously used drugs for allergic rhinitis, you can maintain the medication without change and prescribe additional relief drugs if necessary.

  2. Installation of air purifier and Study I after randomization Randomization is a method that is divided into groups A and B and is assigned based on a randomized list (random table) with statistician advice at a ratio of 1:1 respectively.

    The first study (Study I) will run for four weeks. During this period, the air purifier will continue to operate, and no indoor ventilation will be performed for these four weeks to reduce other factors that may affect indoor air quality. After four weeks, the air purifier will be remotely controlled, and indoor air quality information will be continuously collected in the filter replacement.

  3. Interim Visit (Visit 2) The subject of the study will visit the hospital with a journal written about the changes in symptoms and the use of drugs after the first operation of the purifier (Study I). During the first and second visits, the symptoms will be checked for differences and whether relief drugs have been used, and additional relief drugs will be prescribed if necessary, along with retraining on the next visit schedule.
  4. Study II progress and end visit after replacement of air purifier filter (Visit 3) To proceed with the second study (Study II), LG Electronics installers revisit each home and install Dual Defense Filter (HEPA + VOC capture filter) in Group A. Conversely, Group B will remove the Dual Defense filter and attach void labels again each. Study II will also run for four weeks, during which the air purifier is continuously running and there is no indoor ventilation.

The subject of the study should visit the hospital with symptoms and drug use log even at the end of the visit, and the change in symptoms and the use of relief drugs will be confirmed. At the end of the study, we will disclose which group the study subjects were assigned to.

02

Conditions studied

  • Rhinitis Allergic
03

In context

Rhinitis, Allergic, Perennial

178 studies on the registry are indexed under Rhinitis, Allergic, Perennial; 9 are open to participants now.

This study's planned enrollment of 44 is below the median of 135 across 157 interventional studies indexed under Rhinitis, Allergic, Perennial.

Browse Rhinitis, Allergic, Perennial studies →

Lead sponsor

Yonsei University is the lead sponsor of 1,418 studies on the registry; 241 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adults aged 19 to 60
  • A person with moderate-severe persistent allergic rhinitis diagnosed by an allergy specialist or otolaryngologist and maintained without any change in treatment for more than one month
  • Total nasal symptom Score ≥ 8
  • Patients with allergic rhinitis caused by indoor inhalation antigen antigens (House dust mites ± If the wheal size of the pet skin test is greater than 3mm or the concentration of specific IgE measured by ImmunoCAP ≥ 0.35 kUA/L)
  • A person who spends at least 8 hours/day per week in the home where the cleaner will be installed
  • A person with a wi-fi installed in the home where the purifier will be installed
  • A person who can read and write in Korean
  • A person who fully explains the contents, decides to participate in the study according to his/her free will, and signs a written consent form approved by each agency IRB

Exclusion criteria

Exclusion Criteria:

  • Patients sensitized to seasonal antigens (tree, grass or weed pollen)
  • Rhinitis patients caused by causes other than allergic rhinitis (drug rhinitis, vascular rhinitis, infectious rhinitis, etc.)
  • Anyone who has required more than 2 weeks of systemic use in the last 3 months
  • A person taking antihistamines for reasons other than rhinitis (chronic urticaria, etc.)
  • Those with anatomical abnormalities that cause nasal congestion, such as non-segmental curvature and non-segmental species
  • A person who has a plan to move during the study period or is scheduled to leave where air purifiers are installed for at least five consecutive days (e.g., travel, business trip, etc.)
  • A person who has already used an air purifier within the last three months
  • Pregnant women, lactating women, persons lacking decision-making ability, persons accommodated in facilities
  • A person whose researcher is deemed unfit to participate in clinical research due to other reasons
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
44 participants (estimated)

Study arms

  • Other
    pre-placebo/post-Intervention group

    Group A will receive a fake air purifier during study period 1, and during study 2, the HEPA+VOC filter air purifier will be operated.

    Device: HEPA + VOC collecting filter purifier · Device: fake air purifier

  • Other
    pre-Intervention/post-placebo group

    Group A will receive the HEPA+VOC filter air purifier during study period 1, and during study 2, a fake air purifier will be operated.

    Device: HEPA + VOC collecting filter purifier · Device: fake air purifier

Interventions

  • DeviceHEPA + VOC collecting filter purifier

    Subjects operate HEPA + VOC collecting filter purifier

  • Devicefake air purifier

    Subjects operate fake air purifiers

06

What researchers measure

Primary outcomes

  1. Change of indoor total volatile organic compound concentration

    The indoor air collected through the air purifier is analyzed to evaluate the total indoor volatile organic compound concentration.

    Time frame: up to 12 weeks

Secondary outcomes

  1. Change of indoor formaldehyde concentrations

    Measure the indoor formaldehyde concentration through the air purifier

    Time frame: up to 12 weeks

  2. Change of indoor NO2 concentrations

    Measure the indoor NO2 concentration through the air purifier

    Time frame: up to 12 weeks

  3. Change of indoor PM10 concentrations

    Measure the indoor PM10 concentration through the air purifier

    Time frame: up to 12 weeks

  4. Change of indoor PM2.5 concentrations

    Measure the indoor PM2.5 concentration through the air purifier

    Time frame: up to 12 weeks

  5. Change of indoor PM1.0 concentrations

    Measure the indoor PM1.0 concentration through the air purifier

    Time frame: up to 12 weeks

  6. Change of Allergic rhinitis symptom score (Total natal symtom score)

    TNSS has a total score of 12, and evaluate the degree of runny nose, sneezing, stuffy nose, and itchy nose. A score of 0 is no symptom, a score of 1 is mild (symptomatic/symptomatic but mild and easily tolerable), a score of 2 is moderate (symptomatic/symptomatic but tolerable), and a score of 3 is severe (symptomatic/symptomatic and difficult to bear and interfere with daily life or sleep). the higher the score, the more severe the rhinitis symptoms

    Time frame: up to 12 weeks

  7. Changes in the use of anti-allergic rhinitis medication (Rescue Medication Score)

    Rescue Medication Score is evaluated from 0 to 2. A score of 0 means no additional medication, a score of 1 means additional use of oral or nasal antihistamines, and a score of 2 means additional use of nasal steroids, and a higher score means more rhinitis symptoms

    Time frame: up to 12 weeks

  8. A change in Quality of Life by Allergic Rhinitis

    Evaluate using the quality of life questionnaire. The quality of life evaluation questionnaire is a questionnaire investigating the impact of allergic rhinitis on patients' lives for a week. The higher the score, with a total score of 60, the more severe the symptoms of rhinitis.

    Time frame: up to 12 weeks

  9. Change of odor score

    valuate the subjective level of smell that a subject feels in the home. A score of 0 is odorless (relatively odorless and usually unable to detect anything with his or her sense of smell), a score of 1 is a sensed smell (the smell is unknown but capable of feeling the smell), a score of 2 is a normal smell (the smell is strong enough to know what it is), a score of 3 is a strong smell (the smell is strong enough to detect easily), a score of 4 is an extreme smell (a strong smell, for example, from a conventional toilet in summer), and a score of 5 is an unbearable smell (the strong smell that is difficult to endure and feels like stopping breathing). A total of five points means that the higher the score, the more severe the smell is.

    Time frame: up to 12 weeks

  10. Change in the time required for indoor pollutants to decrease from maximum concentration to baseline

    Through the data collected by the air purifier, the time required for the indoor pollutant source to be reduced from the maximum concentration to the baseline is measured.

    Time frame: up to 12 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06890572
Lead sponsor
Yonsei University
Collaborators
LG Electronics Inc.
Responsible party
Park Kyung Hee (Clinical Associate Professor, Yonsei University) — Principal investigator
First posted
Mar 24, 2025
Start date
Mar 11, 2025
Primary completion
May 23, 2025 (estimated)
Completion
Jun 20, 2025 (estimated)
Last update
Mar 24, 2025

Study contacts

Kyung Hee Park
Contact
white182@yuhs.ac
+82-2-2228-1947
Im Shin
Contact
si1011@yuhs.ac
+82-2-2228-5884
Kyung Hee Park
principal investigator · Yonsei University Health System, Severance Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion